跳至主要内容
临床试验/NCT04664023
NCT04664023已完成不适用

Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 and Its Resolution

Poitiers University Hospital1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2020年12月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
130
试验地点
1
主要终点
T CD8 lymphocytes

研究概览

简要总结

Prospective study to describe the immunological, metabolic and serologic profile in the acute and post acute phases of Coronavirus disease (COVID-19)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

T CD8 lymphocytes

时间窗: At Month 12 after the second injection of vaccine against COVID-19 for volunteers

Blood concentration of glucosidases

Metabolic markers

时间窗: At Month 12 after the second injection of vaccine against COVID-19 for volunteers

Blood concentration of glucosidases

Inflammatory markers

时间窗: At Month 12 after the second injection of vaccine against COVID-19 for volunteers

Blood concentration of glucosidases

Neutralizing antibodies

时间窗: At Month 12 after the second injection of vaccine against COVID-19 for volunteers

Blood concentration of glucosidases

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Description of Immunologic, Enzymatic and Metabolic... | 临床试验